China Resources Jiangzhong Pharmaceutical Co.,Ltd (SHA:600750)
China · Delayed Price · Currency is CNY 23.81
-0.27 (-1.12%)
Aug 14, 2026, 3:00 PM CST
SHA:600750 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 13, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 14,988 | 14,569 | 14,136 | 13,011 | 9,006 | 9,012 | |
Market Cap Growth | 7.99% | 3.07% | 8.64% | 44.47% | -0.07% | 34.83% |
Enterprise Value | 14,755 | 13,116 | 13,744 | 10,846 | 6,989 | 7,382 |
Last Close Price | 23.81 | 22.33 | 20.73 | 18.15 | 11.87 | 10.99 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 13, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 16.55 | 16.07 | 17.93 | 18.11 | 15.06 | 17.82 |
Forward PE | 16.27 | 17.89 | 18.78 | 12.04 | 12.04 | 12.04 |
PS Ratio | 3.68 | 3.45 | 3.19 | 2.86 | 2.32 | 3.14 |
PB Ratio | 2.99 | 3.10 | 3.16 | 2.81 | 2.00 | 1.97 |
P/TBV Ratio | 3.90 | 4.11 | 4.13 | 3.76 | 2.59 | 2.53 |
P/FCF Ratio | 27.65 | 21.11 | 28.53 | 15.71 | 13.32 | 12.37 |
P/OCF Ratio | 18.14 | 15.01 | 17.98 | 12.52 | 8.82 | 9.83 |
PEG Ratio | - | 1.96 | 1.96 | 1.96 | 1.96 | 1.96 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 13, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 3.62 | 3.11 | 3.10 | 2.38 | 1.80 | 2.57 |
EV/EBITDA Ratio | 12.54 | 11.08 | 13.31 | 11.17 | 9.36 | 11.79 |
EV/EBIT Ratio | 14.38 | 12.65 | 15.32 | 12.80 | 11.15 | 14.44 |
EV/FCF Ratio | 27.22 | 19.00 | 27.74 | 13.09 | 10.34 | 10.13 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 13, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0 | 0.00 | 0 | 0 | 0.00 | 0.00 |
Debt / EBITDA Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 |
Debt / FCF Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 |
Net Debt / Equity Ratio | -0.19 | -0.43 | -0.23 | -0.30 | -0.61 | -0.60 |
Net Debt / EBITDA Ratio | -0.80 | -1.72 | -0.98 | -1.42 | -3.67 | -4.42 |
Net Debt / FCF Ratio | -1.73 | -2.95 | -2.05 | -1.67 | -4.05 | -3.80 |
Asset Turnover | 0.59 | 0.63 | 0.69 | 0.72 | 0.63 | 0.53 |
Inventory Turnover | 3.38 | 3.19 | 3.44 | 3.77 | 3.62 | 3.29 |
Quick Ratio | 1.14 | 1.53 | 1.12 | 1.23 | 2.12 | 2.75 |
Current Ratio | 1.86 | 1.80 | 1.40 | 1.54 | 2.42 | 3.09 |
Return on Equity (ROE) | 20.26% | 21.53% | 18.91% | 17.23% | 14.22% | 12.02% |
Return on Assets (ROA) | 9.26% | 9.68% | 8.69% | 8.36% | 6.38% | 5.85% |
Return on Invested Capital (ROIC) | 24.85% | 27.59% | 22.47% | 29.03% | 30.04% | 21.87% |
Return on Capital Employed (ROCE) | 19.40% | 20.80% | 18.90% | 18.00% | 13.60% | 10.90% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 13, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 6.07% | 6.22% | 5.58% | 5.52% | 6.64% | 5.61% |
FCF Yield | 3.62% | 4.74% | 3.50% | 6.37% | 7.51% | 8.08% |
Dividend Yield | 5.80% | 6.18% | 5.79% | 7.16% | 9.69% | 5.91% |
Payout Ratio | 95.91% | 85.80% | 97.50% | 113.62% | 122.54% | 61.97% |
Buyback Yield / Dilution | 0.02% | -0.55% | 12.26% | -14.12% | 0.38% | -0.07% |
Total Shareholder Return | 5.82% | 5.63% | 18.05% | -6.96% | 10.07% | 5.84% |